We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | 3.70 | 3.80 | 3.75 | 3.75 | 3.75 | 257,014 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.58 | 8.09M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/2/2024 08:25 | You've proven time and time again loon you've been wrong | nigelpm | |
29/2/2024 08:23 | You have no idea either nigel. And if you take scare mongering away then it's in everyone's interest to be less dulutive and not take an oversold mark when it's been trading historically much higher. Who knows what strategy they will employ. But cash runway extended and a clear financing support evidenced. Nothing an additional trial conversion wont change. They're not daft and bastians duke are due.. | moontheloon | |
29/2/2024 08:20 | Totally agree nigel this has been on the cards for many months. As far as I'm. Concerned this is toast now. Moon already sat on a 20% loss just from. This mornings stupid top up lmao dread to think how much the rest he's bought are down now. As nigel says give up | bones698 | |
29/2/2024 08:19 | I agree with you Nigel the rate of take up has been slow. However when you read the average time of 18 -24 months, its easy to see why the company is where it is. Going forward all looks reasonable positive. Growth should really ramp up in a few years. Personally ill revisit 2025 | john henry | |
29/2/2024 08:18 | You have no idea of the following and yet it's a great investment: 1) What price you'll be diluted at 2) Whether they'll be able to fund the gap 3) Whether sales traction will work Honestly, some folk need to give this game up. | nigelpm | |
29/2/2024 08:17 | You do that my friend. | moontheloon | |
29/2/2024 08:07 | The only institution has reduced so they won't increase again . | moontheloon | |
29/2/2024 08:06 | Just shows how the uk market is broken, no institutional investment. The institutions that put millions in at much higher levels can't manage to contribute a few million pounds. This will get taken over sometime this year ...another sad day for uk tech and innovation all imo dyor | slicethepie | |
29/2/2024 08:06 | Medtech share issues are often launched at a premium. Every new company needs staged funding to support growth and launch to mainstream | moontheloon | |
29/2/2024 08:05 | 3p anyone it's coming | bones698 | |
29/2/2024 08:04 | Moontheloon you are welcome to pile in as usual, I will wait to see what the actual price is when it is eventually announced. | pj84 | |
29/2/2024 08:04 | Lmao idiot while the sensible sell you buy says it all | bones698 | |
29/2/2024 08:04 | Great for top up which I just happily did | moontheloon | |
29/2/2024 08:03 | There's a level of fantasy in the stockmarket and that is being displayed perfectly this morning. | nigelpm | |
29/2/2024 08:03 | People selling out before the piece gets announced. Says it all 10m dollars won't see them to break even either. This is going to get worse | bones698 | |
29/2/2024 08:02 | "It's a great update" - trades below 5p. | nigelpm | |
29/2/2024 08:00 | Rubbish PJ. Another scurrying from under the stone. Knowing this Is a great update. You are pathetic | moontheloon | |
29/2/2024 07:59 | Pj fair summary but think the price will be lower than you suggest they will get what they can percentage wise so expect it to be quite dilutive. See some on here trying to map it desperately sat on huge losses but reality is they will probably never see. A profit and in fact be resigned to big losses here Speak of the desperate here is moonthe loon lmao | bones698 | |
29/2/2024 07:58 | Thanks Chris for your shrewd professional stewardship . Well done people who didn't fall for the double/triple act on here. Disgusting individuals. | moontheloon | |
29/2/2024 07:57 | The price will be determined by Nukem and Bracco who are the 2 largest and most supportive shareholders. They could maximise the short term benefit to themselves by making it very dilutive but as further fundraises will be required and as they will want some of the other large holders above 3% and private investors to support the balance of the proposed fundraise I would hope they would't make it too dilutive, particularly bearing in mind Nukem paid 6p in January to increase it's stake by 9.5m shares. So 5 to 6p is possible depending on Nukem and Bracco. That said I expect the market to react negatively until the price is announced. | pj84 | |
29/2/2024 07:56 | John Henry is this the same advice as you gave on destvsgaing it wouldn't drop to 30p lol. Fujcing is coming and the ones that have agreed will get them at a favorable price which will be a discount to now imo. Said it would come eventually. I'll stick with 3p price now the market knows what's coming and totally agree commercial progress is non existent here | bones698 | |
29/2/2024 07:56 | Clear growth strategy. Clear financing strategy. Highly supportive strategic investors. Plus Supportive statements. Private health growth of codes from an evidenced stand point.Figures re issued so not as vague about path to profitability.I think they will have something extra to keep this moving into mid teens before any financing launched. | moontheloon | |
29/2/2024 07:55 | Could you squeeze that to 12p ? | bloomberg2 | |
29/2/2024 07:51 | Additional fda avenue for the device which we knew was occurring tbh | moontheloon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions